Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henning, S. M.
Right arrow Articles by Coulson, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henning, S. M.
Right arrow Articles by Coulson, W. F.

The Journal of Nutrition Vol. 127 No. 1 January 1997, pp. 30-36
Copyright ©1997 by the American Society for Nutritional Sciences

Male Rats Fed Methyl- and Folate-Deficient Diets with or without Niacin Develop Hepatic Carcinomas Associated with Decreased Tissue NAD Concentrations and Altered Poly(ADP-ribose) Polymerase Activity1,2

Susanne M. Henning3, Marian E. Swendseid, and Walter F. Coulson*

Community Health Sciences, School of Public Health and * Department of Pathology, School of Medicine, University of California, Los Angeles, CA 90095

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
LITERATURE CITED


ABSTRACT

Folate is an essential cofactor in the generation of endogenous methionine, and there is evidence that folate deficiency exacerbates the effects of a diet low in choline and methionine, including alterations in poly(ADP-ribose) polymerase (PARP) activity, an enzyme associated with DNA replication and repair. Because PARP requires NAD as its substrate, we postulated that a deficiency of both folate and niacin would enhance the development of liver cancer in rats fed a diet deficient in methionine and choline. In two experiments, rats were fed choline- and folate-deficient, low methionine diets containing either 12 or 8% casein (12% MCFD, 8% MCFD) or 6% casein and 6% gelatin with niacin (MCFD) or without niacin (MCFND) and were compared with folate-supplemented controls. Liver NAD concentrations were lower in all methyl-deficient rats after 2-17 mo. At 17 mo, NAD concentrations in other tissues of rats fed these diets were also lower than in controls. Compared with control values, liver PARP activity was enhanced in rats fed the 12% MCFD diet but was lower in MCFND-fed rats following a further reduction in liver NAD concentration. These changes in PARP activity associated with lower NAD concentrations may slow DNA repair and enhance DNA damage. Only rats fed the MCFD and MCFND diets developed hepatocarcinomas after 12-17 mo. In Experiment 2, hepatocarcinomas were found in 100% of rats fed the MCFD and MCFND diets. These preliminary results indicate that folic acid deficiency enhances tumor development. Because tumors developed in 100% of the MCFD-fed rats and because tissue concentrations of NAD in these animals were also low, further studies are needed to clearly define the role of niacin in methyl-deficient rats.

Key words: methyl/folate deficiency, NAD, poly(ADP-ribose)polymerase, hepatocarcinogenesis, rats.


INTRODUCTION

Male rats fed a diet deficient in choline and methionine develop hepatocellular carcinomas without the administration of carcinogenic agents (Ghoshal and Farber 1984, Mikol et al. 1983). In these rats, fat accumulates and there is cell necrosis and increased proliferation of hepatocytes, followed by the development of gamma -glutamyl transferase-positive foci and cirrhosis leading to hepatocellular carcinoma as a final event (Ghoshal and Farber 1993). The diet most frequently used in these long-term studies is the Lombardi diet (Shinozuka et al. 1978), which contains 9% peanut meal and 8% soy protein isolate as major sources of protein and is therefore low in methionine. Additionally, choline is not provided as a supplement. Male rats fed this diet deficient in choline and methionine have a reduced content of hepatic choline (<50% of control), betaine (30% of control), methionine (80% of control), S-adenosylmethionine (SAM)4 (60% of control) and folate (69% of control) (Selhub et al. 1991). These findings indicate that this diet causes a stress on the methyl pool and on the folate-dependent remethylation of homocysteine to methionine. Another diet commonly used for this methyl-deficient rat model is an amino acid-defined diet without choline and low in methionine. Nakae et al. (1992) compared this amino acid-defined, choline-deficient, low-methionine diet to the Lombardi diet and showed a higher incidence of hepatocellular carcinomas with the amino acid-defined diet. The investigators proposed that lack of oligopeptides in the amino acid-defined diet causes less transintestinal absorption of methyl donor amino acids and therefore results in a more severe methyl donor deficiency (Nakae et al. 1992).

Because folate is an essential cofactor in the endogenous formation of methionine from homocysteine, it seems likely that a combined folate-choline-methionine deficiency will cause a more severe methyl donor deficiency than a diet deficient in only choline and methionine. There are a few studies supporting this view (Henning et al. 1989a, Tuma et al. 1975). Feeding rats a diet low in folate, choline and methionine resulted in greater fat accumulation and a lower ratio of SAM to S-adenosylhomocysteine (SAH) in the liver compared with rats fed a diet deficient in only choline and methionine (Henning et al. 1989a). Tuma et al. (1975) also observed an increase in hepatic triglyceride accumulation when the folate antagonist methotrexate was administered to rats in addition to a choline-methionine-deficient diet adequate in vitamin B-12.

In previous experiments (James et al. 1989, Zhang et al. 1993a), we observed that in rats fed a methyl-folate-deficient diet, concentrations of NAD in liver, muscle and spleen were decreased. The activity of poly(ADP-ribose) polymerase (PARP) (EC 2.4.2.3.0), an enzyme requiring NAD as its substrate, was increased in rats fed the methyl-folate-deficient diet at 3 wk (Henning et al. 1989b). Poly(ADP-ribose) polymerase is a nuclear enzyme associated with DNA repair, cell replication and differentiation (Lautier et al. 1993). Poly(ADP-ribosylation) has been linked to tumorigenesis because of its function in the alteration of chromatin structure and regulation of protein activity involved in the metabolism of DNA strand breaks (Boulikas 1991). Experiments with cells in culture and animals showed that inhibitors of PARP activity alter the transformation of cells in vitro and tumorigenicity in vivo (Boulikas 1991). It also was shown that PARP activity was increased in rat liver during 2-acetylaminofluorene-induced hepatocarcinogenesis (Kiehlbauch et al. 1993).

The two experiments described in this article were performed to optimize the carcinogenic effect of methyl-choline-deficient diets. We hypothesize that the carcinogenic effect of a methionine-choline-deficient diet can be enhanced by additional folic acid and niacin deficiencies.


MATERIALS AND METHODS

Animals and experimental diets. Male Fischer 344 rats weighing 60-80 g (Simonsen Laboratory, Gilroy, CA) were housed individually in suspended steel cages with free access to tap water in a room with a 12-h light:dark cycle and a temperature of 21°C. In Experiment 1, 25 rats were randomly assigned to either the control-A or a 12% casein methionine-choline-folate-deficient (12% MCFD) group (Table 1). The control-A diet was the same as the deficient diet but was supplemented with 4 g of L-methionine and 3 mg of folate per kilogram of diet. Rats in the 12% MCFD-fed group were fed this diet for 2 mo to allow growth before this group was subdivided into three dietary treatment groups: Group 1 (n = 4) continued to receive the 12% casein MCFD diet (12% MCFD), Group 2 (n = 7) was fed an 8% casein MCFD (8% MCFD) diet, and Group 3 (n = 7) was fed a 6% casein, 6% gelatin diet deficient in choline, folate and niacin (MCFND-A). Livers of rats fed the 12% MCFD diet did not develop any nodules at 12 mo and feeding of this diet was discontinued. The MCFND-A diet was selected because it had been used successfully in our laboratory to produce NAD deficiency in male rats (Zhang et al. 1993b).

Table 1. Diet composition

[View Table]

For the first 6 mo, rats were weighed and food consumption was determined three times per week, and from 6 to 17 mo these procedures were continued twice per week. After 2 and 6 mo, three or four rats of each group were killed by exsanguination under ether anesthesia, and liver tissue was removed for histologic examination. At 12, 15 and 16 mo, one rat per group was killed; the remaining rats were killed at 17 mo. In addition to the histologic examination, total lipid and PARP activity were determined in liver and the NAD concentration in several tissues.

In Experiment 2, 52 rats were randomly assigned to either a folate-deficient, 6% casein, 6% gelatin, 15% soybean oil diet (MCFD-B) or to the control-B diet, which was a similar diet with both folate and niacin added. Fat concentration in the diets in Experiment 2 was increased to 15 g/100 g and cysteine concentration was halved compared with that of the MCFND-A diet in Experiment 1 to make the diet more similar to the Lombardi diet (Shinozuka et al. 1978). After 2 mo, the MCFD-B-fed group was subdivided, and rats were fed either the MCFD-B (n = 21) or MCFND-B diet (n = 21). The methionine and cysteine concentrations of the diets were calculated to be 7.7, 3.7, 2.5, 2.3, 2.3 and 2.3 g methionine/kg for the control-A, 12% MCFD, 8% MCFD, MCFND-A, control-B and MCFND-B diets, respectively, and 0.46, 0.46, 0.3, 4.3, 2.3 and 2.3 g of cysteine/kg for the control-A, 12% MCFD, 8% MCFD, MCFND-A, control-B and MCFND-B diets, respectively. After 2 and 6 mo, three rats from each group were killed; the remaining rats were killed after 12 or 15 mo. At the end of each time period, blood was collected from the abdominal vein into a heparinized syringe and immediately cooled on ice. Liver, kidney, lung and a piece of skeletal muscle (rectus femoris from the right rear leg) were removed and frozen in small aliquots in liquid nitrogen and stored at -70°C or immediately extracted for NAD determinations. At 12 and 15 mo the number and size of hepatic tumors were evaluated. The procedures for the care and treatment of the rats received prior institutional approval and followed the Guide for the Care and Use of Laboratory Animals (NRC 1985).

Isolation of hepatic nuclei. Liver nuclei were isolated according to the method of Busch (1967). Approximately 1 g of liver was homogenized, and nuclei were separated by centrifugation in solutions with various sucrose concentrations. Finally, nuclei were suspended in 10 mmol/L Tris-HCl, pH 7.4, and the concentration was determined by DNA measurement (Labarca and Paigen 1980).

Determination of hepatic poly(ADP-ribose) polymerase activity and other biochemical assays. The activity of PARP in liver nuclei was determined as described by Henning et al. (1989b). Liver nuclei were incubated in a reaction mix containing [3H]NAD. The reaction was stopped after 30 min with 4 mL of perchloric acid (0.83 mol/L), and the polymer was collected on a membrane filter (Milipore, Bedford, MA). After repeated washing of the filter, the amount of radiolabeled adenosine incorporated into the polymer was counted in a scintillation counter (model LS 9000, Beckman Instruments, Palo Alto, CA). The enzyme cycling method of Nisselbaum and Green (1969) was used to measure the total amount of NAD (oxidized and reduced forms) in various tissues. Biochemical analyses in the late stages of tumor development (12 and 15 mo) were performed on nodular non-tumor tissue.

Histologic tissue examination. Hepatic tissue was fixed in 10% buffered formalin and embedded in paraffin. Sections were stained with routine hematoxylin and eosin and by a trichrome and reticulin method for connective tissue as needed. Lesions were evaluated based on the recommendations of a Working Party of the World Congress of Gastroenterology (1994).

Statistical analysis. Values are expressed as means ± SD. All statistical analyses were performed using SAS for personal computers (version 6.03, SAS Institute, Cary, NC). Data were tested for normality using the Shapiro-Wilk test. If data were normally distributed, the general linear model was used to test for differences due to diet. After a significant F test, Duncan's multiple range test was used to compare group means (Schlotzhauer and Littell 1987). Statistical significance was accepted at P < 0.05. If data were not normally distributed, differences were tested using the Kruskal-Wallis test, a nonparametric analog to the one-way ANOVA in the SAS-NPAR1WAY procedure (Schlotzhauer and Littell 1987).


RESULTS

Growth rate and food consumption. In both experiments, weight gain was significantly lower in rats fed the different methyl-folate-deficient diets. In Experiment 1, food intake was not different for rats fed the methyl-folate-deficient diets and controls. In Experiment 2, rats fed the MCFD-B and MCFND-B diets consumed less food than did controls (Table 2). Because weight gain was also lower in these rats, food consumption per kilogram of body weight was higher than in controls, resulting in greater micronutrient consumption per kilogram of body weight.

Table 2. Weight gain and food consumption in Fischer 344 rats fed methyl-folate-deficient diets with or without niacin1

[View Table]

NAD and NADP concentration in whole blood and tissues. All water-soluble compounds determined in liver were evaluated per gram of fat-free liver. In Experiment 1 the hepatic NAD concentration was significantly lowered to 61 and 54% of control values at 6 mo and to 77% and 43% of control values at 17 mo in rats fed the 8% MCFD and MCFND-A diets, respectively (Table 3). Muscle and whole-blood NAD levels were also lowered with decreasing dietary methyl content at 17 mo. Kidney and lung NAD levels were determined at 17 mo and were significantly lower in rats fed the MCFND-A diet compared with controls. The NADP levels were 77 and 56% of control values in liver and were 65 and 44% of control values in muscle in rats fed the 8% MCFD and MCFND-A diets, respectively (data not shown).

Table 3. Concentrations of NAD in tissues of Fischer 344 rats fed methyl-folate-deficient diets with or without niacin for 6 and 17 mo (Exp. 1)1

[View Table]

In Experiment 2, NAD levels were significantly lower in whole blood and liver at all time intervals in rats fed the methyl-deficient diets compared with control rats (Table 4). Muscle NAD was significantly lower only after 15 mo. Liver NADP concentrations were also lower in rats fed the MCFD-B and MCFND-B diets compared with those fed the control diet. Whole-blood NADP, however, was not different (Table 4).

Table 4. Total liver lipid and NAD concentrations in tissues of Fischer 344 rats fed methyl-folate-deficient diets with or without niacin for 2 to 15 mo (Exp. 2)1

[View Table]

Hepatic total lipid concentration. In Experiment 1, hepatic total lipid was significantly higher in all methyl-folate-deficient rats compared with controls (Table 5). Hepatic lipid concentration was higher with decreasing methyl content of the diet: control <12% MCFD < 8% MCFD. In rats fed diet additionally niacin deficient (MCFND-A), hepatic lipid concentrations were lower after 6 mo than in the 8% MCFD-fed rats but not significantly different after 17 mo. In Table 4 similar effects are shown for Experiment 2. 

Table 5. Liver concentrations of total lipid and activity of poly(ADP-ribose) polymerase (PARP) in Fischer 344 rats fed methyl-folate-deficient diets with or without niacin for 2 to 17 mo (Exp. 1)1

[View Table]

Hepatic poly(ADP-ribose) polymerase activity. In Experiment 1, at 2 mo in rats fed the 12% MCFD diet, hepatic PARP activity was significantly higher than in control rats. At 6 mo the activity was lower in the MCFND-A-fed rats compared with the controls but not significantly different in 8% or 12% MCFD-fed rats than in controls. At 17 mo, rats fed the 8% MCFD diet had greater PARP activity than controls or rats fed MCFND-A (Table 5).

Tumor development and pathologic features. As shown in Table 6, tumors developed after 17 mo only in livers of rats fed the 6% casein, 6% gelatin, folate-niacin-deficient (MCFND-A) diet (Experiment 1) and after 12 and 15 mo in rats fed the 6% casein, 6% gelatin diet with and without niacin (MCFD-B, MCFND-B) (Experiment 2). At 6 mo, livers of rats fed the 6% gelatin, 6% casein diet showed severe fatty change, predominantly macrovesicular, with bridging fibrosis evolving to established cirrhosis (Fig. 1A). At 15 mo there was striking macronodulation. Within such a nodule, the normal architecture was completely lost, replaced by solid areas, a pseudoglandular pattern and so-called "floating trabeculae" (Fig. 1B). Portal tracts were absent. The liver cells showed both large and small cell changes with high grade nuclear abnormalities, including pleomorphism, prominent nucleoli with irregularly clumped chromatin, and high mitotic activity with bizarre forms (Fig. 1C). Such features are consistent with moderately differentiated hepatocellular carcinoma. Livers of rats fed either the 8% or 12% casein diet did not show any apparent alterations compared with control rats, even at 17 mo (Table 6).

Table 6. Number and size of tumors developed in Fischer 344 rats fed methyl-folate-deficient diets with or without niacin1

[View Table]



Fig. 1. Typical histopathological appearance of liver tissue of a rat fed the MCFND-B diet. A. Severe hepatocellular steatosis with bridging fibrosis, evolving to cirrhosis (hematoxylin and eosin, ×60). B. Macronodular architecture showing a solid area with large cell dysplasia on the left and a pseudo-papillary "floating" pattern of smaller cells on the right. The normal plate structure, including portal tracts, is completely absent (hematoxylin and eosin, ×140). C. High power view of liver cells from a solid area, showing nuclear pleomorphism and numerous mitotic figures (at least five in this field), some of them bizarre (non-mirror image) (hematoxylin and eosin, ×350).
[View Larger Versions of these Images (168 + 133 + 124K GIF file)]

In Experiment 2, 100% of rats fed the MCFD-B and MCFND-B diets developed tumors. Some tumors were first detected at 12 mo (Table 6). The number and size of tumors was increased at 15 mo. There were no significant differences in the number or size of tumors that developed in rats fed the MCFD-B and MCFND-B diets.


DISCUSSION

Previous reports on diet-induced liver cancer in rats have used diagnostic histological criteria similar to those developed for human tumors (Farber 1976, Mikol et al. 1983). The most recent proposal for standardizing such criteria in assessing nodules in human liver cirrhosis has been provided by a Working Party of the World Congress of Gastroenterology (1994). Their classification separates all hepatocellular lesions into three groups: regenerative, dysplastic or neoplastic nodules (hepatocellular adenoma), and hepatocellular carcinoma. Their characteristics are well described in the "Terminology of Nodular Hepatocellular Lesions" (Working Party of the World Congress of Gastroenterology 1994) and by Watanabe et al. (1983).

The lesions in the methyl-folate-deficient rats fall into all three of the above categories. Most importantly, the largest nodules exhibit complete loss of plate architecture with focal pseudoglandular change, absent portal tracts, and marked nuclear pleomorphism with prominent mitosis. By both present and older criteria these nodules represent hepatocellular carcinoma of moderate differentiation. The certain criterion for malignancy is metastasis, which was not encountered in our animals, possibly because they were not allowed to live long enough. There were no spontaneous deaths. A test of malignancy by growing the tumor cells in culture is planned with the next experiment.

All rats fed the methyl-deficient diets in both experiments showed typical effects of a methyl donor deficiency, such as fatty livers, decreased hepatic SAM concentration and either increased or unaltered hepatic SAH levels (data not shown). In Experiment 1, decreasing the methionine in the diet by decreasing the casein content increased the severity of the effects. In both experiments, however, hepatocellular carcinomas developed only in rats fed the 6% gelatin, 6% casein diet with or without niacin. Rats fed either the 12 or 8% casein diet did not develop carcinomas, although the methionine contents of the 8% casein (2.5 g/kg diet) and 6% casein and gelatin diet (2.3 g/kg diet) were similar. One striking difference in the amino acid composition of casein and gelatin is that gelatin contains more glycine than does casein (MCFD-B, 14.9 g/kg diet; 8% MCFD, 1.6 g/kg diet). In an experiment by Krumdieck et al. (1992), a severe shift in the folylpolyglutamate distribution towards shorter forms was observed in livers of rats receiving supplemental glycine (25 g/kg diet). More than a 10-fold increase in monoglutamate and a reduction of hexa- and pentaglutamates were observed. Although these rats had a normal folic acid intake, the total liver folates in these rats dropped to about one third of control levels. It is possible that also in the case of the MCFD-B diet the high glycine content caused a further decrease in liver folate levels and therefore rendered rats more methyl deficient.

In Experiment 2, 100% of rats fed the casein-gelatin diets (MCFD-B and MCFND-B) developed tumors, whereas in the first experiment only one out of four rats fed the MCFND-A diet showed hepatocarcinomas. The MCFD-B and MCFND-B diets contained 2.3 g of methionine, no choline, no folate and 10 µg of vitamin B-12 per kilogram of diet. In experiments in which Fischer 344 rats were fed the Lombardi diet, 20-50% of the rats were reported to develop hepatocellular carcinoma after 11-24 mo (Ghoshal and Farber 1984, Mikol et al. 1983, Nakae et al. 1992). The Lombardi diet contained 2 g of methionine, traces of choline, 10 µg of vitamin B-12 and 2 mg of folate per kilogram of diet. The diet composition in regard to the methionine, choline, cysteine and oil content of the Lombardi diet is very similar to the diet used in our laboratory except for the absence of folate and increase in glycine. We hypothesize that the folate deficiency, enhanced by the increased glycine content, leads to a more severe methyl donor deficiency and an increased carcinogenic effect. This is not surprising because the endogenous formation of methionine from homocysteine depends on folate as a cofactor (Krumdieck 1990). If the folic acid supply is compromised, less methionine is formed and less S-adenosylmethionine is available for methylation. In Experiment 2, weight gain was significantly decreased in methyl-folate-deficient rats (fed the MCFD-B and MCFND-B diets) compared with controls although the food intake was increased per kilogram of body weight. Comparing the effect of our diet on weight gain with that of the choline-deficient Lombardi diet, rats fed the Lombardi diet did not show this reduction in weight gain compared with the choline-sufficient controls (Chandar and Lombardi 1988). The pattern of weight reduction in Experiment 2 again reinforces the hypothesis that the additional folate deficiency leads to a more severe methyl donor deficiency, which is reflected in the reduced weight gain compared with that of rats fed the Lombardi diet.

No differences were found in either number and size of tumors in rats fed the MCFD-B or MCFND-B diet. In rats fed the MCFND-B diet, tissue and plasma NAD levels were not significantly different from those of rats fed the diet containing niacin (MCFD-B). Rats apparently had enough NAD through the conversion of tryptophan to maintain niacin levels as in those fed MCFD-B. To produce a more severe niacin deficiency, it may be necessary to reduce the amount of tryptophan in the diet.

In previous publications it has been shown that the PARP activity was increased in livers of methyl-deficient rats after 3 wk (Henning et al. 1989b). In the present study, the hepatic PARP activity was enhanced during a mild reduction in hepatic NAD concentrations (about 80% of controls), and the activity was lower than that of controls following a further reduction in NAD concentration (<60% of control) (Table 3). Because DNA strand breaks have been reported in the choline-folate-deficient rat model (James et al. 1989), we hypothesize that PARP activity was stimulated by DNA strand breaks to facilitate DNA repair. Stimulation of PARP activity may lead to a reduction of NAD below 60% of the control value leading to an inhibition of PARP activity, as observed in livers of rats fed the MCFND-A diet. The NAD concentrations were decreased in liver and blood at 6 mo, and at 17 mo other tissues showed alterations in NAD levels, suggesting a general change in niacin metabolism, possibly secondary to alterations in PARP activity. These alterations in PARP activity and NAD may slow DNA repair processes and increase DNA damage.

Only rats fed the MCFND-A, MCFD-B and MCFND-B diets developed hepatocarcinomas after 12-17 mo. Because all rats fed the MCFD-B diet developed tumors, the effect of a concomitant niacin-deficient diet could not be ascertained. In summary, this study provides preliminary results that methyl-deficient diets devoid of folic acid enhance tumor development. Additional studies are required to resolve the question of whether tumor development will be influenced by a more severe niacin deficiency.


FOOTNOTES

1   Supported in part by NIH grant CA 42710-10 and by Westreco Inc., Van Nuys, CA.
2   The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
3   To whom correspondence should be addressed.
4   Abbreviations used: MCFD, methyl-choline-folate deficient; MCFND, methyl-choline-folate-niacin deficient; PARP, poly(ADP-ribose) polymerase; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine.

Manuscript received 3 June 1996. Initial reviews completed 30 July 1996. Revision accepted 26 September 1996.


LITERATURE CITED


0022-3166/97 $3.00 ©1997 American Society for Nutritional Sciences



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. A. Sauve
NAD+ and Vitamin B3: From Metabolism to Therapies
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 883 - 893.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-M. Tong, U. Cortes, M. P. Hande, H. Ohgaki, L. R. Cavalli, P. M. Lansdorp, B. R. Haddad, and Z.-Q. Wang
Synergistic Role of Ku80 and Poly(ADP-ribose) Polymerase in Suppressing Chromosomal Aberrations and Liver Cancer Formation
Cancer Res., December 1, 2002; 62(23): 6990 - 6996.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R.S. Okoji, R.C. Yu, R.R. Maronpot, and J.R. Froines
Sodium arsenite administration via drinking water increases genome-wide and Ha-ras DNA hypomethylation in methyl-deficient C57BL/6J mice
Carcinogenesis, May 1, 2002; 23(5): 777 - 785.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. A. Caudill, J. C. Wang, S. Melnyk, I. P. Pogribny, S. Jernigan, M. D. Collins, J. Santos-Guzman, M. E. Swendseid, E. A. Cogger, and S. J. James
Intracellular S-Adenosylhomocysteine Concentrations Predict Global DNA Hypomethylation in Tissues of Methyl-Deficient Cystathionine {beta}-Synthase Heterozygous Mice
J. Nutr., November 1, 2001; 131(11): 2811 - 2818.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. A. Jacob, D. M. Gretz, P. C. Taylor, S. J. James, I. P. Pogribny, B. J. Miller, S. M. Henning, and M. E. Swendseid
Moderate Folate Depletion Increases Plasma Homocysteine and Decreases Lymphocyte DNA Methylation in Postmenopausal Women
J. Nutr., July 1, 1998; 128(7): 1204 - 1212.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henning, S. M.
Right arrow Articles by Coulson, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henning, S. M.
Right arrow Articles by Coulson, W. F.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 1997 by American Society for Nutrition